NEW YORK (Reuters Health) – Vandetanib shows encouraging action against advanced and metastatic medullary thyroid carcinoma, researchers report in an October 24th on-line paper in the Journal of…
NEW YORK (Reuters Health) – In patients with chronic coronary artery disease, prasugrel overcomes high on-clopidogrel platelet reactivity more effectively than doubling the dose of clopidogrel, results of…
NEW YORK (Reuters Health) – More intensive blood glucose lowering won’t reduce the risk of heart failure in patients with type 2 diabetes, and when achieved with a…
NEW YORK (Reuters Health) – Thoracoscopic unilateral extended thymectomy (TUET) is “the best treatment option” for patients undergoing surgery for nonthymomatous myasthenia gravis, clinicians from Romania conclude in…
NEW YORK (Reuters Health) – Older patients with advanced hematologic malignancies and comorbid conditions can successfully undergo nonmyeloablative allogeneic hematopoietic cell transplantation (HCT), results of a new study…
NEW YORK (Reuters Health) – The institution of lipid-lowering therapy has significantly reduced mortality in patients with homozygous familial hypercholesterolemia (FH), researchers from South Africa report in the…
NEW YORK (Reuters Health) – Nail bed hemorrhage may serve as a clinical marker of optic disc hemorrhage in patients with glaucoma, researchers from South Korea report in…
NEW YORK (Reuters Health) – Prasugrel helps stop thrombotic events in patients who undergo percutaneous coronary intervention (PCI), but associated “nuisance” bleeding may prompt discontinuation of such therapy,…
NEW YORK (Reuters Health) – Percutaneous edge-to-edge mitral valve repair using the MitraClip device can be safely performed even in very high risk patients, researchers from Germany report…
NEW YORK (Reuters Health) – Polycystic ovary syndrome (PCOS) does not appear to increase the risk of cardiovascular events among postmenopausal women, researchers from Sweden report in the…
